Femur

Stryker launches Gamma4 Hip Fracture Nailing System in Europe

Retrieved on: 
Tuesday, March 26, 2024
General Health, Surgery, Medical Devices, Health, Health Technology, Certification, Database, Gamma, CE, Hip, Fracture, Femur, Surgeon, Workflow, Trochanter, SYK, Precision, Multimedia, Nail, Feedback

Stryker (NYSE:SYK), a global leader in medical technologies, today announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets.

Key Points: 
  • Stryker (NYSE:SYK), a global leader in medical technologies, today announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets.
  • The newest Gamma system will provide surgeons with the next generation of Stryker’s intramedullary nailing system.
  • The Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons.
  • The new Gamma4 system redefines hip fracture care with sleek instrumentation, advanced nail design and improved geometry collectively, ensuring a lasting impact on orthopaedic practices for years to come.”

First Skeleton-Wide Study of Blood Cell Formation Yields Surprising Findings

Retrieved on: 
Wednesday, March 20, 2024
Humerus, Cell, Bone marrow, Infection, Disease, Bleeding, Laser, Mechanics, Anatomy, Mouse, Research, Nature, Experimental Hematology, Doctor of Philosophy, Femur, Human, Sternum, Arteriole, Neutrophil, Blood, G-CSF, Division, Marker beacon, Tibia, Skull, Skeleton, Ageing, Vaccine

CINCINNATI, March 20, 2024 /PRNewswire/ -- Imagine being able to count the different types of blood cells being formed inside the tiny bones of a mouse and pinpointing the strings and clusters of cells within the bone marrow that are responsible for producing specific types of blood cells.

Key Points: 
  • "Meanwhile, efforts to stimulate production of certain blood cell types may be dramatically improved by focusing on specific bone types."
  • The key discoveries reported in the paper include:
    New tools allowing visualization of blood production inside the bone, allowing defining the basic anatomy of blood cell formation.
  • Among several examples: blood loss triggered rapid red blood cell production in the sternum, tibia, vertebrae, and humerus -- but not in the skull.
  • Importantly, the process developed for this study allowed the team to analyze blood cell development in multiple parts of the skeleton.

Dror Paley, MD to Lead World's First Surgery with the PRECICE® Max System at Paley Orthopedic & Spine Institute

Retrieved on: 
Tuesday, February 20, 2024
PALM, Reconstruction, Weight-bearing, Globus Medical, Tibia, FDA, Femur, History, Health, NSO, Patient, Ageing, MAX, Birth control

WEST PALM BEACH, Fla,, Feb. 20, 2024 /PRNewswire-PRWeb/ -- Dr. Dror Paley, a globally renowned orthopedic surgeon and the Founder & CEO of the Paley Orthopedic & Spine Institute, is set to make medical history as he performs the first surgery in the world utilizing the PRECICE® Max System, developed by NuVasive Specialized Orthopedics™ (NSO), now a part of Globus Medical. This groundbreaking surgery marks a significant step forward in orthopedic innovation, emphasizing Dr. Paley's steadfast dedication to advancing the field and improving patient care. Furthermore, his selection as the inaugural surgeon further solidifies his reputation as the foremost authority in Limb Lengthening Deformity & Reconstruction Surgery worldwide.

Key Points: 
  • This groundbreaking surgery marks a significant step forward in orthopedic innovation, emphasizing Dr. Paley's steadfast dedication to advancing the field and improving patient care.
  • Furthermore, his selection as the inaugural surgeon further solidifies his reputation as the foremost authority in Limb Lengthening Deformity & Reconstruction Surgery worldwide.
  • Reflecting on the significance of this advancement, Dr. Paley stated, "I'm thrilled about the new Precice Max nail that I've contributed to developing.
  • As a global leader in orthopedic surgery, Dr. Paley's dedication to innovation and patient well-being shapes the future of orthopedic medicine.

Tyber Medical Acquires FDA Clearance for Proximal Tibia Plating System

Retrieved on: 
Monday, February 12, 2024
Tibia, FDA, Food, Injury, Regulatory affairs, Femur, Food and Drug Administration, Fibula, Anatomy, Trauma

BETHLEHEM, Pa., Feb. 12, 2024 /PRNewswire/ -- Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, has received a U.S. Food and Drug Administration (FDA) 510(k) approval for its Proximal Tibia Plating System. The Tyber Medical System consists of two indication categories: Complete Articular and Partial Articular Fractures. Both designs stabilize bone fragments to facilitate highly focused and efficient healing of a wide array of injuries to the tibia, fibula, and femur. "This innovative addition to the Tyber Medical portfolio aligns to meet the needs of our customers by offering multiple solutions to challenging anatomy," commented David Hannah, Chief Technology Officer at Tyber Medical. Mr. Hannah added. "This comprehensive system offers anatomic plating to support a wide range of trauma needs."

Key Points: 
  • BETHLEHEM, Pa., Feb. 12, 2024 /PRNewswire/ -- Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, has received a U.S. Food and Drug Administration (FDA) 510(k) approval for its Proximal Tibia Plating System.
  • The Tyber Medical System consists of two indication categories: Complete Articular and Partial Articular Fractures.
  • The Tyber Medical Proximal Tibial Plating System is engineered to accommodate surgeon preferences, increase procedural efficiency, and enhance plate fit and screw placement.
  • Lisa Boyle, Director of Regulatory Affairs commented "With the clearance of the Proximal Tibial Plating System and its sub-categories, Tyber Medical remains unwavering in our commitment to providing cutting edge orthopedic solutions."

New Study Identifies Increased Fracture Risk for Older Pickleball Players

Retrieved on: 
Monday, February 12, 2024
SAN, Cleveland Clinic, Fracture, Woman, MD, Injury, Female, Calcium, Database, Hospital, Risk, Vitamin D, Prevalence, Femur, University, Pickleball, Nutrient, Sport, Ukactive, Commission, Literature, AAOS, Ageing, Osteoporosis, Hip, American Academy

The Sports and Fitness Industry Association identified an 11.5% average annual growth rate of pickleball players over the past five years, with approximately 1.4 million "core" players (those who play more than eight times per year) in 2020.

Key Points: 
  • The Sports and Fitness Industry Association identified an 11.5% average annual growth rate of pickleball players over the past five years, with approximately 1.4 million "core" players (those who play more than eight times per year) in 2020.
  • A highlight of findings from the study include:
    Throughout the study, there was a 90-fold increase in fractures, with a noticeable surge from 2020 onward where fractures doubled.
  • Despite the female predominance in fractures, men were 2.3 times more likely to be admitted for a fracture.
  • "It's important to understand your risk profile of injury and to speak with your physician to see how you can lower your risk.

New Intermediate Nail and RC Lag Screw Expand Gamma4 Portfolio to Meet the Needs of Surgeons and Their Patients

Retrieved on: 
Wednesday, January 17, 2024
Medical Supplies, Technology, Managed Care, Health, General Health, Radiology, Health Technology, Medical Devices, Hospitals, Surgery, Hardware, Femur, Trochanter, Hip, Fracture, MediSys Health Network, Multimedia, Rotation, Hip fracture, Orthopedic surgery, SYK, Jamaica Hospital Medical Center, Surgeon, RC

“Stryker remains unwavering in our commitment to providing cutting-edge orthopaedic solutions to meet the needs of our customers.

Key Points: 
  • “Stryker remains unwavering in our commitment to providing cutting-edge orthopaedic solutions to meet the needs of our customers.
  • The recent line extension, including the Gamma4 intermediate nail and RC Lag Screw, received 510(k) clearance in June 2023.
  • Hip fractures with involvement of the basicervical neck region can be provisionally stabilized with the anti-rotation clip and sleeve during lag screw insertion.
  • The Phase 2 launch of these additional Gamma4 features will expand the surgeon's toolbox and add to an already best-of-class nailing system.”

NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury

Retrieved on: 
Thursday, December 21, 2023
Veteran, Osteocalcin, Skeleton, Risk, Osteoporosis, Immobilization, Fracture, Messenger, Tibia, Tetraplegia, BSP, Society, Osteoblast, Cancer, Femur, Blood, S15, Manuscript, Patient, Therapy, Osteoclast, BMD, Medical imaging

The data demonstrated that NC605, a novel anti-Siglec-15 (S15) antibody, prevented bone loss, but more importantly preserved bone strength in animal models of severe immobilization resulting from acute spinal cord injury.

Key Points: 
  • The data demonstrated that NC605, a novel anti-Siglec-15 (S15) antibody, prevented bone loss, but more importantly preserved bone strength in animal models of severe immobilization resulting from acute spinal cord injury.
  • Following spinal cord injury, patients typically suffer rapid and extensive bone loss.
  • While anti-resorptive therapies have shown some efficacy in inhibiting bone loss, these agents also inhibit bone formation.
  • Blood and bone structure analyses revealed that the anti-S15 antibody was able to greatly inhibit bone resorption while maintaining bone formation and quality.

OrthoPediatrics Corp. Announces Launch of Specialty Bracing Division

Retrieved on: 
Wednesday, December 6, 2023
Hip, Partnership, Levity, Brace, Immobilization, Knee, Acquisition, Trauma, Surgeon, Injury, Clubfoot, Femur, MDO, Elective surgery, Growth, Patient, AFO, OPSB, Dentistry

WARSAW, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of a new division, focused on non-surgical intervention for pediatric orthopedics.

Key Points: 
  • WARSAW, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of a new division, focused on non-surgical intervention for pediatric orthopedics.
  • The OrthoPediatrics Specialty Bracing division (“OPSB”) will serve as a flagship house of brands and innovative products that expand the Company’s Total Addressable Market by approximately $600 million.
  • Since the transaction, the Company has been aggressively building a portfolio of complementary products to address the large unmet needs for specialty bracing within the pediatric orthopedic market.
  • OrthoPediatrics’ President of Trauma & Deformity Correction, Joe Hauser will also lead the new non-operative business, commenting, “We are excited for the launch of the new OPSB division, and our continued expansion into pediatric orthopedic non-surgical treatments for kids.

Jury Returns $680,656 Verdict for Child Injured at Trampoline Park - Viñas & DeLuca, PLLC

Retrieved on: 
Friday, December 15, 2023
Fault, Femur, DeLuca, Risk, Defendant, Fracture, Plaintiff, Child, Lawyer, Court, Dentistry

TAMPA, Fla., Dec. 15, 2023 /PRNewswire-PRWeb/ -- A jury in Tampa, FL returned a verdict of $680,656.00 on May 11, 2023, finding that the negligence of Summit Adventure Park Spring Hill, a now defunct Tampa-based trampoline park, caused injury to an 11-year-old boy. The minor was injured while playing on one of the park's trampoline attractions called the "Wipeout Arm." Following the trial, the Court reduced the jury's verdict to account for the way certain medical bills were paid and awarded the Plaintiff litigation expenses incurred in prosecuting the case. The total recovery obtained by the Plaintiff was $687,972.91.

Key Points: 
  • Trampoline park tragedy - An 11-year-old boy suffered an injury at a now-defunct trampoline park based in Tampa, Florida.
  • A jury has concluded that Summit Adventure Park Spring Hill was negligent and responsible for the causing injury.
  • TAMPA, Fla., Dec. 15, 2023 /PRNewswire-PRWeb/ -- A jury in Tampa, FL returned a verdict of $680,656.00 on May 11, 2023, finding that the negligence of Summit Adventure Park Spring Hill, a now defunct Tampa-based trampoline park, caused injury to an 11-year-old boy.
  • The minor was injured while playing on one of the park's trampoline attractions called the "Wipeout Arm."

OrthoPediatrics Corp. Launches DF2 Brace®

Retrieved on: 
Tuesday, October 10, 2023
Hip, Knee, Standard of care, Deformity, Elective surgery, Femur, Injury, Spica, Immobilization, Orthopediatrics, Patient, Dentistry, Trauma

WARSAW, Ind., Oct. 10, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the limited release of the DF2® Brace as part of its expansion in the non-surgical business for treating kids with musculoskeletal injuries.

Key Points: 
  • WARSAW, Ind., Oct. 10, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the limited release of the DF2® Brace as part of its expansion in the non-surgical business for treating kids with musculoskeletal injuries.
  • The DF2® Brace is intended for femur fracture fixation in pediatric patients from approximately 6 months to 5 years of age instead of spica cast by providing immobilization of the femur, knee, and hip.
  • Spica casts for femur fractures are considered the standard of care and have been used for decades, so the DF2® brace represents a significant advancement in how kids with femur fractures can be treated.
  • Joe Hauser, President of Trauma and Deformity Correction at OrthoPediatrics, added, “This is the first product launch for the OrthoPediatrics Specialty Bracing group and will significantly improve the care of kids with femur fractures.